Sort
40,608 grants matching “prostate cancer”
ANDROGEN INDEPENDENT PROSTATE CANCER:A TRANSGENIC MODEL
$364,963Baylor College Of Medicine · R01 · FY2003 · CA
Genetics and Biology of Metastatic Colorectal Cancer
$364,755Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Genetics and Biology of Metastatic Colorectal Cancer
$364,755Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Genetics and Biology of Metastatic Colorectal Cancer
$364,755Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Enabling Technology to Study Mechanosensitive and Mechanoresistant Cancer Cells in Flow
$364,723Michael R King · Rice University · R01 · FY2024 · CA
Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer
$364,651Subhamoy Dasgupta · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Selenium Chemoprevention: Benefits and Harms
$364,639Elizabeth T Jacobs · University Of Arizona · R01 · FY2020 · CA
A genomewide study of lung cancer in never smokers
$364,638Olga Gorlova · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
$364,601David Gius · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Sonic hedgehog, a regulator of CN injury induced apoptosis
$364,580Carol Ann Podlasek · Northwestern University At Chicago · R01 · FY2010 · DK
Selenium Chemoprevention: Benefits and Harms
$364,547Elizabeth T Jacobs · University Of Arizona · R01 · FY2021 · CA
Detection, Monitoring, and Cancer Risk of Endocrine disruptors in U.S. Water Systems
$364,512Gordon L Hager · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
PSMA TARGETED NANO-RADIOIMMUNOTHERAPY FOR PROSTATE CANCER
$364,500Sanford Research · · FY2008 · Department of the Army
ASPN, A NOVEL INHIBITOR OF TGFBETA AND A PUTATIVE BIOMARKER FOR AGGRESSIVE PROSTATE CANCER
$364,500The Johns Hopkins University · · FY2012 · Department of the Army
MODULATION OF BETA-CATENIN ACTIVITY WITH PKD1 IN PROSTATE CANCER
$364,500Sanford Research · · FY2008 · Department of the Army
The NEDD8 pathway mediated Skp2 degradation in chemoprevention by FKA
$364,385Xiaolin Zi · University Of California-Irvine · R01 · FY2018 · CA
Role of Shh in developmental patterning and growth of digit skeleton
$364,377Susan Mackem · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Growth differentiation control in primary keratinocytes
$364,342Gian Paolo Dotto · Massachusetts General Hospital · R01 · FY2018 · AR
Growth differentiation control in primary keratinocytes
$364,342Gian Paolo Dotto · Massachusetts General Hospital · R01 · FY2020 · AR
Growth differentiation control in primary keratinocytes
$364,342Gian Paolo Dotto · Massachusetts General Hospital · R01 · FY2019 · AR
Growth differentiation control in primary keratinocytes
$364,342Gian Paolo Dotto · Massachusetts General Hospital · R01 · FY2017 · AR
Restless Legs Syndrome, Cardiovascular Risk Factors, and Cardiovascular Events
$364,331Tobias Kurth · Brigham And Women'S Hospital · R01 · FY2009 · HL
X-ray Targeted Therapeutic Genes within Nanoparticles
$364,320Dennis E Hallahan · Vanderbilt University · R01 · FY2007 · CA
Natural History of Biochemically Recurrent Prostate Cancer
$364,304Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Evaluation of novel treatments in biochemically recurrent prostate
$364,304Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA